| Year | Speaker and Lecture Details |
|---|---|
| 2016 | Michael Bracken, Ph.D., M.P.H., FACE. Yale School of Public Health Inefficiency and Waste in Biomedical Research: How Prevalent Is It, What Are Its Causes, and How Is It Prevented? |
|
2015 |
Shiriki K. Kumanyika, Ph.D., M.P.H. Perelman School of Medicine at the University of Pennsylvania Research Directions for Solving the Obesity Epidemic in High-Risk Populations |
|
2014 |
Moyses Szklo, M.D., Dr.P.H., M.P.H. Johns Hopkins University Bloomberg School of Public Health, Baltimore Epidemiology: Back to Translation |
| 2013 | Mitchell Gail, M.D., Ph.D. Division of Cancer Epidemiology & Genetics, National Cancer Institute Using Risk Models for Breast Cancer Prevention |
| 2012 | Lewis H. Kuller, M.D., Dr.P.H., University of Pittsburgh Graduate School of Public Health The Obesity Epidemic: Why Have We Failed? |
| 2011 | Jonathan Samet, M.D., Johns Hopkins University Bloomberg School of Public Health, Baltimore Big Epidemiology for Big Problems |
| 2010 | Julie E. Buring, Sc.D., Harvard Medical School, Boston What Do We Do When Studies Disagree? |
| 2009 | Leon Gordis, M.D., Dr.P.H., M.P.H., Johns Hopkins University, Baltimore Epidemiology at the Interface of Science, Policy, and Politics: Are New Directions Needed for Epidemiology Training Today? |
| 2008 | Alice S. Whittemore, Ph.D., Stanford University School of Medicine, California Personalizing Cancer Prevention |
| 2007 | Robert N. Hoover, M.D., Sc.D., The National Cancer Institute, NIH Hormones & Breast Cancer: Etiology vs. Ideology |
| 2006 | Steven N. Blair, P.E.D., The Cooper Institute, Texas Physical Inactivity: The Biggest Public Health Problem in the 21st Century |
| 2005 | Jo Ann Manson, M.D., Dr.P.H., Harvard Medical School, Boston Post-Menopausal: Can Divergent Findings from Clinical Trials and Observational Studies Be Reconciled? |
| 2004 | Elizabeth Barrett-Connor, M.D., University of California, San Diego Diversity, Body Size and Diabetes: Genetics Without Genotyping |
| 2003 | Jeremiah Stamler, M.D., Northwestern University Nutrition, Blood Pressure, Cholesterol and Low Risk |
| 2002 | Sir Richard Peto, F.R.S., University of Oxford, UK Halving Premature Death |
| 2001 | David L. DeMets, Ph.D., University of Wisconsin, Madison Managing and Monitoring Multicenter Clinical Trials: Who Is in Charge of What? |
| 2000 | Steven R. Cummings, M.D., FACP, University of California, San Francisco New Technology and a Two-Edged Sword: How Bone Densitometry Has Revolutionized and Impeded the Understanding and Prevention of Osteoporotic Fractures |
| 1999 | Walter C. Willett, M.D., Dr.P.H., Harvard Medical School, Boston Diet and Coronary Heart Disease: Have We Misled the Nation? |
| 1998 | Alfred Sommer, M.D., M.H.S., Johns Hopkins University School of Hygiene and Public Health, Baltimore Epidemiology in the Cause of Vitamin A: Science to Practice |
| 1997 | Jean W. MacCluer, Ph.D., University of Texas Health Science Center, San Antonio From Epidemiology to Gene Discovery: Finding Genes for Complex Diseases |
| 1996 | Joseph F. Fraumeni, Jr., M.D., Sc.M., Director, Division of Cancer Epidemiology and Genetics, National Cancer Institute Epidemiology of Cancer: An Interdisciplinary Approach |
| 1995 | Charles H. Hennekens, M.D., Dr.P.H., John Snow Professor of Medicine and Ambulatory Care and Prevention, Harvard Medical School Aspirin in the Secondary and Primary Prevention of Cardiovascular Disease |
Archived Content
The Office of Disease Prevention (ODP) archives materials that are more than 3 years old and no longer being updated. Over time, links and other information may have changed. We cannot guarantee that all of the links in these materials will be current or accurate.
Robert S. Gordon, Jr. Lecture in Epidemiology
Last updated on February 27, 2020